Rekah Pharmaceutical Industry Ltd. Stock price

Equities

REKA

IL0010810096

Pharmaceuticals

Market Closed - TEL AVIV STOCK EXCHANGE 11:24:58 2024-03-28 am EDT 5-day change 1st Jan Change
1,376 ILa +4.40% Intraday chart for Rekah Pharmaceutical Industry Ltd. -3.64% -6.90%

Financials

Sales 2021 264M 71.72M 26.4B Sales 2022 292M 79.45M 29.24B Capitalization 176M 47.73M 17.57B
Net income 2021 6M 1.63M 600M Net income 2022 -2M -543K -200M EV / Sales 2021 1.56 x
Net Debt 2021 147M 39.99M 14.72B Net Debt 2022 145M 39.51M 14.54B EV / Sales 2022 1.1 x
P/E ratio 2021
40.1 x
P/E ratio 2022
-85.5 x
Employees 399
Yield 2021
3.73%
Yield 2022
-
Free-Float 17.36%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.40%
1 week-3.64%
Current month-0.72%
1 month-2.69%
3 months-8.33%
6 months-22.65%
Current year-6.90%
More quotes
1 week
1 313.00
Extreme 1313
1 450.00
1 month
1 313.00
Extreme 1313
1 479.00
Current year
1 313.00
Extreme 1313
1 507.00
1 year
1 313.00
Extreme 1313
1 887.00
3 years
1 313.00
Extreme 1313
2 700.00
5 years
1 313.00
Extreme 1313
2 908.00
10 years
856.10
Extreme 856.1
4 076.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 80 93-08-23
Director of Finance/CFO 44 18-10-31
Director/Board Member 78 93-08-23
Members of the board TitleAgeSince
Director/Board Member 62 15-04-14
Director/Board Member 52 15-04-14
Chairman 77 15-04-14
More insiders
Date Price Change Volume
24-03-28 1,376 +4.40% 3,385
24-03-27 1,318 -2.15% 5,908
24-03-26 1,347 -2.46% 9,823
24-03-25 1,381 -3.29% 4,657
24-03-21 1,428 -1.18% 91

Delayed Quote TEL AVIV STOCK EXCHANGE, March 28, 2024 at 11:24 am EDT

More quotes
Rekah Pharmaceutical Industry Ltd. (Rekah) is an Israel-based company which operates directly and through its subsidiaries. The Company operates two Good Manufacturing Practice (GMP) approved manufacturing sites, it has a marketing and distribution arm, a chain of pharmacies, and an export import unit. Rekah's plant covers approximately 5,000 square meters and was designed to take advantage of the most advanced and automated packaging techniques available. In April 1995, Rekah received the approval of the Ministry of Health for its new facility. The sterile department was designed to meet the standard of the United States Food and Drug Administration and was opened in February 1997. The Company distributes its products through Ophir & Shalpharm to institutional users such as Israel Health Funds, hospitals and government health facilities. Other subsidiaries include Vitamed Pharmaceutical Industry Ltd., CenterPharm, RITE, Talmor, BARBARA WOLF Ltd. and Madad.
More about the company
  1. Stock
  2. Equities
  3. Stock Rekah Pharmaceutical Industry Ltd. - TEL AVIV STOCK EXCHANGE